174 related articles for article (PubMed ID: 25265947)
1. HDAC4 blocks autophagy to trigger podocyte injury: non-epigenetic action in diabetic nephropathy.
Wei Q; Dong Z
Kidney Int; 2014 Oct; 86(4):666-8. PubMed ID: 25265947
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy.
Wang X; Liu J; Zhen J; Zhang C; Wan Q; Liu G; Wei X; Zhang Y; Wang Z; Han H; Xu H; Bao C; Song Z; Zhang X; Li N; Yi F
Kidney Int; 2014 Oct; 86(4):712-25. PubMed ID: 24717296
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 4 mediates high glucose-induced podocyte apoptosis via upregulation of calcineurin.
Shi W; Huang Y; Zhao X; Xie Z; Dong W; Li R; Chen Y; Li Z; Wang W; Ye Z; Liu S; Zhang L; Liang X
Biochem Biophys Res Commun; 2020 Dec; 533(4):1061-1068. PubMed ID: 33019979
[TBL] [Abstract][Full Text] [Related]
4. Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy.
Liu F; Zong M; Wen X; Li X; Wang J; Wang Y; Jiang W; Li X; Guo Z; Qi H
Sci Rep; 2016 Sep; 6():33676. PubMed ID: 27633396
[TBL] [Abstract][Full Text] [Related]
5. Cyclo-RGD Truncated Polymeric Nanoconstruct with Dendrimeric Templates for Targeted HDAC4 Gene Silencing in a Diabetic Nephropathy Mouse Model.
Raval N; Jogi H; Gondaliya P; Kalia K; Tekade RK
Mol Pharm; 2021 Feb; 18(2):641-666. PubMed ID: 32453574
[TBL] [Abstract][Full Text] [Related]
6. Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat.
Khan S; Jena G; Tikoo K; Kumar V
Biochimie; 2015 Mar; 110():1-16. PubMed ID: 25572918
[TBL] [Abstract][Full Text] [Related]
7. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
[TBL] [Abstract][Full Text] [Related]
8. Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy.
Zhang L; Wen Z; Han L; Zheng Y; Wei Y; Wang X; Wang Q; Fang X; Zhao L; Tong X
J Diabetes Res; 2020; 2020():7504798. PubMed ID: 32695831
[TBL] [Abstract][Full Text] [Related]
9. PRMT1 mediates podocyte injury and glomerular fibrosis through phosphorylation of ERK pathway.
Zhu Y
Biochem Biophys Res Commun; 2018 Jan; 495(1):828-838. PubMed ID: 29129692
[TBL] [Abstract][Full Text] [Related]
10. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
[TBL] [Abstract][Full Text] [Related]
11. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury.
Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H
FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113
[TBL] [Abstract][Full Text] [Related]
12. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH)-dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox 2 (ZEB2) in the glomerular podocyte: a novel action of gh with implications for the pathogenesis of diabetic nephropathy.
Kumar PA; Kotlyarevska K; Dejkhmaron P; Reddy GR; Lu C; Bhojani MS; Menon RK
J Biol Chem; 2010 Oct; 285(41):31148-56. PubMed ID: 20682777
[TBL] [Abstract][Full Text] [Related]
14. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy.
Tung CW; Hsu YC; Shih YH; Chang PJ; Lin CL
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():32-37. PubMed ID: 30298646
[TBL] [Abstract][Full Text] [Related]
15. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte.
Jin J; Shi Y; Gong J; Zhao L; Li Y; He Q; Huang H
Stem Cell Res Ther; 2019 Mar; 10(1):95. PubMed ID: 30876481
[TBL] [Abstract][Full Text] [Related]
16. Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy.
Dai H; Liu Q; Liu B
J Diabetes Res; 2017; 2017():2615286. PubMed ID: 28791309
[TBL] [Abstract][Full Text] [Related]
17. Podocyte hypertrophy in diabetic nephropathy.
Kim NH
Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
[TBL] [Abstract][Full Text] [Related]
18. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
[TBL] [Abstract][Full Text] [Related]
19. Method and its Composition for encapsulation, stabilization, and delivery of siRNA in Anionic polymeric nanoplex: An In vitro- In vivo Assessment.
Raval N; Jogi H; Gondaliya P; Kalia K; Tekade RK
Sci Rep; 2019 Nov; 9(1):16047. PubMed ID: 31690769
[TBL] [Abstract][Full Text] [Related]
20. Wnt signaling and podocyte dysfunction in diabetic nephropathy.
Bose M; Almas S; Prabhakar S
J Investig Med; 2017 Dec; 65(8):1093-1101. PubMed ID: 28935636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]